Today on Outsourcing-Pharma.com   Merck confirms diabetes retreat BMS to shell out $715m for IT services BioWa and Lonza agreement for potent antibodies NNE wins Pronova contract Eli Lilly signals vigour for outsourcing

Related Industry News   Roche targets Ventana's board to force takeover Eisai continues biologics push with $3.9bn MGI Pharma buy Abbott cuts jobs, closes plant in Ireland Almirall takes on big pharma in COPD

Breaking News on Outsourcing Pharma
Daily  Wednesday 12 December 2007		Forward to a colleague

	Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here Access Full Stories Merck confirms diabetes retreat Merck Serono intends to forge ahead with severing its investment in diabetes and either sell or partner out its existing research and development (R&D) activities in this field, which it no longer feels able... Read BMS to shell out $715m for IT services Bristol-Myers Squibb (BMS) has agreed to shell out $715m over seven years in a new outsourcing deal with US-based IT services firm EDS... Read BioWa and Lonza agreement for potent antibodies BioWa and Lonza are joining forces to develop a new technology platform to produce more potent antibodies with enhanced cell-killing powers... Read NNE wins Pronova contract NNE Pharmaplan has won a contract with Pronova BioPharma to build the company's new pharma production facility in Kalundborg, Denmark... Read Eli Lilly signals vigour for outsourcing Eli Lilly is the latest big pharma company to signal plans of a vigorous commitment to outsourcing in a bid to prevent its fortunes fading... Read
	All News Headlines for: December | November | October
	Related Industry News Roche targets Ventana's board to force takeover The latest twist in Roche's long-running bid to acquire diagnostics expert Ventana has seen the pharma giant announce it intends to elect directors to Ventana's board at its next AGM (annual general meeting)... Read Eisai continues biologics push with $3.9bn MGI Pharma buy Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and strengthen its oncology pipeline... Read Abbott cuts jobs, closes plant in Ireland Abbott is to shut its doors on its Galway, Ireland, facility - taking 500 jobs with it - as the market moves into murky waters over the future of vascular stents... Read Almirall takes on big pharma in COPD Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Previous Headlines Hikma still in 'acquisition mode' on APM buy Hikma has ticked another pharma firm off its shopping list as it acquires the Arab Pharmaceutical Manufacturing Company (APM) for $163.6m... Read GSK allies with OncoMed to beat cancer stem cells GlaxoSmithKline (GSK) and OncoMed are teaming up to develop novel antibody therapies that target the cancer stem cells believed to play a key role in forming cancers... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving ClinTec, Synexus, Tripos, Qualia, Icon, and Encorium Group... Read Puerto Rico pursuing biologic bucks Puerto Rico is making a concerted effort to attract biologic investment dollars onto the island as it falls foul of a retreat from pharma firms seeking solid dose manufacturing... Read Two early-phase CROs merge Two US players in the early-phase contract research organisation (CRO) space have announced their intentions to merge... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com